Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities
Yuxiang Zhang, David Remillard, Ugoma Onubogu, Barbara Karakyriakou, Joshua N. Asiaban, Anissa R. Ramos, Kirsten Bowland, Timothy R. Bishop, Paige Barta, Stephanie Nance, Adam D. Durbin, Christopher J. Ott, Michalina Janiszewska, Benjamin F. Cravatt, Michael A. Erb
Topics & Concepts
BiologyChromatinHistone deacetylase 2Histone deacetylaseHDAC1EnhancerHistoneGeneticsChromatin remodelingCancer researchCell biologyTranscription factorComputational biologyGeneHistone Deacetylase Inhibitors ResearchProtein Degradation and InhibitorsUbiquitin and proteasome pathways